Scarica l'app Stockscreener
33.23
1.16%
0.38
Dopo l'orario di chiusura:
33.23
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Azenta Inc Borsa (AZTA) Ultime notizie
Azenta Inc (AZTA) Trading 3.24% Higher on Jun 18 - GuruFocus
Shareholders in Azenta (NASDAQ:AZTA) have lost 59%, as stock drops 3.6% this past week - Yahoo Finance
SG Americas Securities LLC Has $1.07 Million Stock Position in Azenta, Inc. (NASDAQ:AZTA) - Defense World
GAMMA Investing LLC Increases Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
California State Teachers Retirement System Sells 5,299 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by Deutsche Bank AG - Defense World
Cetera Investment Advisers Sells 539 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Millennium Management LLC Purchases 17,899 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Is Now An Opportune Moment To Examine Azenta, Inc. (NASDAQ:AZTA)? - Yahoo
Azenta, Inc. (NASDAQ:AZTA) Position Lessened by Man Group plc - Defense World
Enhance Laboratory Efficiency with Azenta’s CryoPod Carrier - Lab Manager
Ameriprise Financial Inc. Increases Holdings in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Captrust Financial Advisors Acquires 2,026 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
The Manufacturers Life Insurance Company Has $447,000 Holdings in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Announces Leadership Change with New General Counsel - TipRanks
Azenta Life Sciences and Form Bio Announce Strategic Partnership - GuruFocus
Northern Trust Corp Reduces Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta (AZTA) Partners with Form Bio to Advance AAV Gene Therapy - GuruFocus
Azenta, Form Bio Launch Partnership for AAV Gene Therapy - marketscreener.com
Azenta Life Sciences And Form Bio Announce Strategic Partnership To Advance AAV Gene Therapy Development - marketscreener.com
Azenta, Form Bio announce strategic partnership - TipRanks
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - Nasdaq
Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Voya Investment Management LLC - Defense World
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 - Seeking Alpha
AZTA Q1 Earnings Call: Revenue Tops Expectations, Margin Progress Amid Macro Headwinds - FinancialContent
Price T Rowe Associates Inc. MD Increases Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - The AM Reporter
Needham & Company LLC Lowers Azenta (NASDAQ:AZTA) Price Target to $40.00 - Defense World
Balance Sheet Insights: Azenta Inc (AZTA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 - MSN
Azenta, Inc. (NASDAQ:AZTA) Q2 2025 Earnings Call Transcript - Insider Monkey
First Trust Advisors LP Buys New Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... - Yahoo
Azenta (NASDAQ:AZTA) Hits New 1-Year Low Following Weak Earnings - Defense World
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic Challenges - GuruFocus
Azenta, Inc. Reports Solid Q2 2025 Revenue Growth - TipRanks
Azenta, Inc. Reports Strong Q2 2025 Earnings - TipRanks
Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stoc - GuruFocus
Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion By Investing.com - Investing.com South Africa
Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stock News - GuruFocus
Transcript : Azenta, Inc., Q2 2025 Earnings Call, May 07, 2025 - marketscreener.com
Needham Adjusts Price Target on Azenta to $40 From $59, Keeps Buy Rating - marketscreener.com
Earnings call transcript: Azenta’s Q2 2025 results miss EPS forecast, stock rises - Investing.com Australia
Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion - Investing.com India
Azenta Fiscal Q2 Non-GAAP Earnings Fall, Revenue Rises - marketscreener.com
Azenta Surpasses Revenue Expectations in Q1 CY2025News and Statistics - IndexBox
Azenta (NASDAQ:AZTA) Beats Q1 Sales Targets - FinancialContent
Azenta (AZTA) Reports Q2 Earnings with Revenue Decline - GuruFocus
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 | AZTA Stock News - GuruFocus
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 - Quantisnow
Azenta expands PCR plate range - European Pharmaceutical Manufacturer
Azenta (AZTA) Q1 Earnings Report Preview: What To Look For - FinancialContent
S&P Dow Jones Indices Announces Changes to MidCap 400 and SmallCap 600 - SDx Central
Top investors say Azenta Inc (AZTA) ticks everything they need - Sete News
Examining Azenta Inc (AZTA) stock is warranted - uspostnews.com
Azenta Inc [AZTA] Insider Hughes Violetta sells 317 Shares - knoxdaily.com
Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast - Kilgore News Herald
Raymond James Financial Inc. Purchases Shares of 46,612 Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Inc (AZTA)’s Market Momentum: Closing Strong at 27.02, Up 1.08 - DWinneX
0.32%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):